Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasmsEva Tiensuu Janson, Ulrich Knigge, Halfdan Sørbye et al.|Acta Oncologica|2014Cited by 118
Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with 177Lu-DOTATATEAchyut Ram Vyakaranam, Anders Sundin, Joakim Crona et al.|Cancers|2019Cited by 81
Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumoursEva Tiensuu Janson, Ulrich Knigge, Halfdan Sørbye et al.|Acta Oncologica|2010Cited by 77
Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine TumoursÉric Raymond, Nicola Fazio, Paul Ruff et al.|Neuroendocrinology|2018Cited by 55
CLC and IFNAR1 are differentially expressed and a global immunity score is distinct between early- and late-onset colorectal cancerTrude H. Ågesen, Rolf I. Skotheim, Marianne Berg et al.|Genes and Immunity|2011Cited by 51